ISOCHEMIX
IsoChemiX is a unique new UK pharmaceutical and clinical discovery company based in the University of East Anglia. IsoChemiX was recently spun out of the University Chemistry Department, which ranked 4th in the UK in 2014, and rated as "excellent" for its research output by the UK government. This gives IsoChemiX first class facilities on which to base operations, as well as strong knowledge and connectivity in the commercial areas the business places focus on. IsoChemix is a contract supplier... of stable isotope labelled small molecules encompassing starting materials and end products. The emphasis on contract synthesis is informed by our research activities in the use of stable isotopes and their behaviours, as well as core knowledge in the build up of complex structural motifs in the laboratory with PhD qualified staff. IsoChemiX is consultancy-driven and highly client centric ensuring you get the molecules you need. This strength of knowledge empowers our clients with value-added chemistry and biochemistry to drive pivotal results. The company manufactures exclusively in the UK enabling it to deliver complex chemistry to what would otherwise represent challenging timescales.
ISOCHEMIX
Industry:
Life Science Medical Pharmaceutical
Address:
Norwich, Norfolk, United Kingdom
Country:
United Kingdom
Website Url:
http://www.isochemix.com
Status:
Active
Contact:
+44(0)1603 597674
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API LetsEncrypt Apple Mobile Web Clips Icon Font Awesome Euro Microsoft Exchange Online Office 365 Mail
Similar Organizations
Genochem
Genochem is a preclinical and early clinical drug discovery company.
Magnapharm Hungary
MagnaPharm is a pharmaceuticals and consumer health company.
Synopharm
Synopharm is operates as a trading company for pharmaceutical and raw materials.
The Research Network
The Research Network is a Pharmaceutical R&D Scientific Consultancy, Project Management, Outsourcing, Training And Due Diligence Services.
TML
TML is an online pharmaceutical and medical store.
Official Site Inspections
http://www.isochemix.com Semrush global rank: 5.12 M Semrush visits lastest month: 729
Unable to get host informations!!!
More informations about "IsoChemiX"
IsoChemiX - Craft
IsoChemiX is a pharmaceutical discovery company. Its services include the clinical discovery of complex molecules, contract synthesis of pro-drugs, full active pharmaceutical ingredients, …See details»
IsoChemiX - Crunchbase Company Profile & Funding
IsoChemiX is a unique new UK pharmaceutical and clinical discovery company based in the University of East Anglia. IsoChemiX was recently spun out of the University Chemistry …See details»
Ischemix | Cytoprotective Therapies
Ischemix, Inc. is developing novel, proprietary cytoprotective compounds for the treatment of serious diseases and conditions. Our lead compound, CMX-2043, is in preclinical …See details»
Ischemix - Crunchbase Company Profile & Funding
Ischemix, Inc., a pharmaceutical company, develops small molecule drugs for the treatment and prevention of ischemia-reperfusion injury. Its product includes CMX-2043, a cardio-protective …See details»
Ischemix Company Profile 2024: Valuation, Funding & Investors
Ischemix General Information Description. Developer of therapeutic compounds intended for the treatment of serious diseases and conditions. The company's primary focus of the company is …See details»
About - Ischemix
About Ischemix. Ischemix is a privately-held pharmaceutical company that is developing novel cytoprotective compounds for serious diseases and conditions. Accomplishments. Proof of …See details»
IsoChemiX - Products, Competitors, Financials, Employees, …
IsoChemiX is a pharmaceutical research and development company. Use the CB Insights Platform to explore IsoChemiX's full profile.See details»
IsoChemiX - Crunchbase
IsoChemiX is a unique new UK pharmaceutical and clinical discovery company.See details»
Ischemix - Overview, News & Similar companies | ZoomInfo.com
Aug 25, 2023 Ischemix contact info: Phone number: (508) 839-2999 Website: www.ischemix.com What does Ischemix do? Ischemix is a privately-held drug development …See details»
IsoChemix - Overview, News & Competitors | ZoomInfo.com
View IsoChemix (www.isochemix.com) location in Vermont, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
ISOCHEMIX LIMITED: Contact Details and Business Profile
ISOCHEMIX LIMITED is a Business Services, Research, and Life Science company located in Norwich, Norfolk with $4.00 Million in revenue and 2 employees. Find top employees, contact …See details»
Find and update company information - GOV.UK
ISOCHEMIX LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activitySee details»
Ischemix Company Profile - Office Locations, Competitors ... - Craft
Ischemix is a pharmaceutical company developing cytoprotective compounds for serious neurological diseases and conditions. Its lead compound, CMX-2043, is in preclinical …See details»
IsoChemiX - LinkedIn
IsoChemiX | 21 followers on LinkedIn. Stable Isotope Labelled Compound Synthesis | IsoChemiX: your drug and clinical discovery partner Bespoke Stable Isotope Labelling & Analysis …See details»
News - Ischemix
Altasciences Company, Inc. a contract research organization offering a broad array of drug development services, performed the Phase 1 trial at its Montreal, Quebec, Canada facility. ...See details»
Ischemix - Products, Competitors, Financials, Employees, …
About Ischemix. Ischemix is a pharmaceutical company focused on developing cytoprotective therapies for the treatment of serious diseases. The company's main product is a proprietary …See details»
Ischemix - Contacts, Employees, Board Members, Advisors & Alumni
Ischemix has 1 current employee profile, Co-founder and Consultant Howard Schneider. Howard Schneider Co-founder and Consultant Unlock even more features with Crunchbase ProSee details»
Ischemix, Inc. Completes Successful Phase 1 Trial of Novel …
Aug 25, 2023 Ischemix, Inc.,a privately-held company focused on developing cytoprotective therapeutics for serious medical conditions, today announced that it has completed an 80 …See details»
Ischemix, Inc. Completes Successful Phase 1 Trial of Novel
Aug 25, 2023 Altasciences Company, Inc. a contract research organization offering a broad array of drug development services, performed the Phase 1 trial at its Montreal, Quebec, …See details»
Treatment of Acute Traumatic Brain Injury with a Novel …
Nov 21, 2023 Ischemix, Inc.’s drug candidate, CMX-2043, is a novel, patented, cytoprotective compound in development for the treatment of acute traumatic brain injury (TBI). CMX-2043 …See details»